Related content

Persistent ascites resolving with gonadotropin-releasing-hormone-agonist 18 months after hospitalization for severe ovarian hyperstimulation syndrome

By Comba Cihan   Ugurlucan Funda   Bastu Ercan   Iyibozkurt Ahmet   Topuz Samet  

Archives of Gynecology and Obstetrics, Vol. 289, Iss. 1, 2014-01 ,pp. : 223-225

Springer Publishing Company

Access to resources Recommend Favorite

Two rare events in one patient undergoing assisted conception: empty follicle syndrome and ovarian hyperstimulation with the sole administration of a gonadotropin-releasing hormone agonist - low-dose side effects in women and monkeys

By Khalaf Y.   Anderson H.   Taylor A.   Braude P.  

Fertility and Sterility, Vol. 73, Iss. 1, 2000-01 ,pp. : 171-172

Elsevier

Access to resources Recommend Favorite

Is coasting effective for preventing ovarian hyperstimulation syndrome in patients receiving a gonadotropin-releasing hormone antagonist during an in vitro fertilization cycle?

By Delvigne A.   Carlier C.   Rozenberg S.  

Fertility and Sterility, Vol. 76, Iss. 4, 2001-10 ,pp. : 844-846

Elsevier

Access to resources Recommend Favorite

Minimal ovarian hyperstimulation for in vitro fertilization using sequential clomiphene citrate and gonadotropin with or without the addition of a gonadotropin-releasing hormone antagonist

By Williams S.C.   Gibbons W.E.   Muasher S.J.   Oehninger S.  

Fertility and Sterility, Vol. 78, Iss. 5, 2002-11 ,pp. : 1068-1072

Elsevier

Access to resources Recommend Favorite

Gonadotropin-Releasing Hormone (GnRH)-Antagonist Versus GnRH-Agonist in Ovarian Stimulation of Poor Responders Undergoing IVF

By Fasouliotis Sozos J.   Laufer Neri   Sabbagh-Ehrlich Shelley   Lewin Aby   Hurwitz Arye   Simon Alex  

Journal of Assisted Reproduction and Genetics, Vol. 20, Iss. 11, 2003-11 ,pp. : 455-460

Springer Publishing Company

Access to resources Recommend Favorite